Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
Immunocore Holdings (NasdaqGS:IMCR) has been drawing attention after recent share price moves, with the stock down 3.6% over the past month but up 2% in the past 3 months. See our latest analysis for Immunocore Holdings. At a share price of $32.55, Immunocore's recent 7 day share price return of a 7.16% decline and 30 day share price return of a 3.64% decline sit against a 1 year total shareholder return of 4.43% and a 3 year total shareholder return of a 48.58% decline. This suggests short term momentum has cooled while longer term holders have still faced meaningful volatility. If Immunocore has put biotech on your radar, it can be worth widening the lens to other specialist names by scanning healthcare stocks as a source of fresh ideas. With the shares at $32.55, a modelled intrinsic value gap and a wide spread to the average analyst target hint at potential upside. But are you looking at a genuine opportunity here, or is the market already pricing in future growth? With
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of DirectorsBusiness Wire
- Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.MarketBeat
- Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]Yahoo! Finance
- Levicept Announces the Appointment of James Sandy as Chief Development OfficerGlobeNewswire
- Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]Yahoo! Finance
IMCR
Earnings
- 11/6/25 - Beat
IMCR
Sec Filings
- 1/30/26 - Form 8-K
- 1/9/26 - Form 8-K
- 12/8/25 - Form 4
- IMCR's page on the SEC website